Supplements

In the Evolving Mystery of BV, an Innovative Oral Treatment Emerges

Publish date: January 24, 2018
This supplement is sponsored by Symbiomix Therapeutics, LLC (a Lupin Company).

 

Click Here to Read the Supplement

Topics include:

  • BV terminology and treatment over time
  • Current understanding of BV etiology
  • BV consequences
  • BV treatments
  • Future research needs in BV

Author:
Steven E. Chavoustie, MD, FACOG, CCRP

University of Miami

Miller School of Medicine

Miami, Florida

Click Here to Read the Supplement

Recommended Reading

Is mannitol a good alternative agent for evaluating ureteral patency after gynecologic surgery?
MDedge ObGyn
Clinical trial: Study underway of robot-assisted surgery for pelvic prolapse
MDedge ObGyn
Product Update: MyoSure MANUAL; Rivanna's Accuro 3D; PeriGen; Instavit
MDedge ObGyn
Laparoscopic nerve-sparing approach is effective in deep infiltrating endometriosis
MDedge ObGyn
Questions value of ACOG/SMFM guidelines
MDedge ObGyn
Unnecessary laparotomy: $625,000 award
MDedge ObGyn
Teens with PID underscreened for HIV, syphilis
MDedge ObGyn
Alopecia tied to nearly fivefold increase in fibroids in African American women
MDedge ObGyn
FDA issues safety measures for all gadolinium-based contrast agents for MRI
MDedge ObGyn
Protocols to reduce opioid use and shorten length of stay
MDedge ObGyn